SC 13D Filing

Company

OnKure Therapeutics, Inc.

Filed

December 26, 2023

Accession Number

0001214659-23-016861

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →